Literature DB >> 976303

Haemodynamic effects of procainamide and phenytoin at apparent therapeutic plasma levels.

E Karlsson, C Sonnhag.   

Abstract

The haemodynamic effects of procainamide and phenytoin after intravenous administration to 19 patients with suspected congenital heart lesions were studied. The drugs were injected into the pulmonary artery in a dose of 5 mg per kg bodyweight, at an infusion rate of 50 mg per minute, thus giving plasma concentrations within the suggested therapeutic ranges. The diastolic pressures in the pulmonary artery and the right ventricle were reduced by procainamide and the converse effect was noted after phenytoin. The heart rate was significantly increased by both drugs but with phenytoin this effect was only transitory. The latter drug also caused a small and transient fall in cardiac output and mean arterial pressure. It was concluded that of the two drugs phenytoin seemed to have the most marked myocardial depressant effect.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 976303     DOI: 10.1007/BF00565618

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  24 in total

1.  Value and hazards of intravenous procaine amide ("pronestyl") therapy.

Authors:  N S STEARNS; E J CALLAHAN; L B ELLIS
Journal:  J Am Med Assoc       Date:  1952-02-02

Review 2.  The current status of diphenylhydantoin in heart disease.

Authors:  E N Mercer; J A Osborne
Journal:  Ann Intern Med       Date:  1967-11       Impact factor: 25.391

3.  Procainamide dosage schedules, plasma concentrations, and clinical effects.

Authors:  J Koch-Weser; S W Klein
Journal:  JAMA       Date:  1971-03-01       Impact factor: 56.272

4.  Lack of effect of procainamide on ventricular function of conscious dogs.

Authors:  R A O'Rourke; V S Bishop; H L Stone; E Rapaport
Journal:  Am J Cardiol       Date:  1969-02       Impact factor: 2.778

5.  Fatal results from diphenylhydantoin administered intravenously.

Authors:  M A Russell; G Bousvaros
Journal:  JAMA       Date:  1968-11-25       Impact factor: 56.272

6.  The hemodynamic effects of diphenylhydantoin.

Authors:  R D Conn; J W Kennedy; J R Blackmon
Journal:  Am Heart J       Date:  1967-04       Impact factor: 4.749

7.  Cardiac and peripheral vascular effects of diphenylhydantoin sodium.

Authors:  C G Mixter; J M Moran; W G Austen
Journal:  Am J Cardiol       Date:  1966-03       Impact factor: 2.778

8.  Fatal ventricular fibrillation following intravenous sodium diphenylhydantoin therapy.

Authors:  G L Gellerman; C Martinez
Journal:  JAMA       Date:  1967-04-24       Impact factor: 56.272

9.  The effect of diphenylhydantoin sodium (Dilantin) on myocardial contractility and hemodynamics.

Authors:  P S Puri
Journal:  Am Heart J       Date:  1971-07       Impact factor: 4.749

10.  Death following intravenous sodium diphenylhydantoin (dilantin).

Authors:  G C Voigt
Journal:  Johns Hopkins Med J       Date:  1968-10
View more
  4 in total

1.  Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Circulation       Date:  2010-10-19       Impact factor: 29.690

2.  Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Pediatrics       Date:  2010-10-18       Impact factor: 7.124

3.  Serum procainamide levels as therapeutic guides.

Authors:  J Koch-Weser
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

4.  Peri-operative prophylaxis with phenytoin: dosage and therapeutic plasma levels.

Authors:  A Levati; G Savoia; F Zoppi; L Boselli; C Tommasino
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.